Abstract Aim The “2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure”
replaces the “2013 ACCF/AHA Guideline for the Management of Heart Failure” and the …

Background The effects of omega-3 fatty acids (FAs), such as eicosapentaenoic (EPA) and
docosahexaenoic (DHA) acids, on cardiovascular outcomes are uncertain. We aimed to …

version of the Guidelines, which is freely available via the ESC and EAS websites and
hosted on their journals' websites (EHJ and Atherosclerosis Journal). The National Cardiac …

The observation that heart failure with reduced ejection fraction is associated with elevated
circulating levels of pro-inflammatory cytokines opened a new area of research that has …

Background: High intake of marine n-3 polyunsaturated fatty acids (PUFA) has been
associated with reduced risk of cardiovascular events; however, this has not been confirmed …

Background Increased intake of n− 3 fatty acids has been associated with a reduced risk of
cardiovascular disease in observational studies, but this finding has not been confirmed in …

Background Researchers have suggested that omega‐3 polyunsaturated fatty acids from
oily fish (long‐chain omega‐3 (LCn3), including eicosapentaenoic acid (EPA) and …

Omega-3 polyunsaturated fatty acids (PUFAs) include α-linolenic acid (ALA; 18: 3 ω-3),
stearidonic acid (SDA; 18: 4 ω-3), eicosapentaenoic acid (EPA; 20: 5 ω-3) …

The concept that inflammation participates pivotally in the pathogenesis of atherosclerosis
and its complications has gained considerable attention, but has not yet entered clinical …

Background Higher intake of marine n− 3 (also called omega-3) fatty acids has been
associated with reduced risks of cardiovascular disease and cancer in several observational …